Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size
ORIGINAL ARTICLE
Year : 2011  |  Volume : 6  |  Issue : 4  |  Page : 193-198

Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia


1 Department of Surgery Section Head liver Surgery-King Fahd General Hospital, Jeddah, Saudi Arabia
2 Medical manager, Sanofi-Aventis, Jeddah, Saudi Arabia
3 Department of Intensive Care, King Abdul-Aziz Medical City, King Saud Bin Abdul-Aziz University for Health Sciences, National Guard Health Affairs NGHA, and Head of SAVTE Group Jeddah, Saudi Arabia

Correspondence Address:
Fahad Al-Hameed
Department of Intensive Care, King Abdul-Aziz Medical City, King Saud Bin Abdul-Aziz University for Health Sciences, P.O. Box 9515, Jeddah-21423
Saudi Arabia
Login to access the Email id

Source of Support: The authors have received unrestricted grant from Sanofi Avantis, Jeddah, KSA, Conflict of Interest: Sharif Galal is an employee at Sanofi Avantis, Jeddah, KSA

DOI: 10.4103/1817-1737.84772

Rights and Permissions

DOI: 10.4103/1817-1737.84772

Rights and Permissions

Background: Venous thromboembolism (VTE) is a serious and underestimated potentially fatal disease with an effective prophylactic antithrombotic therapy that is usually underused. Objectives: The primary study objective is to determine the percentage of VTE patients who received prophylactic antithrombotic therapy according to ACCP guidelines. Secondary study objectives are determining prevalence of confirmed VTE mortality among all cause hospital mortalities, measuring adherence to anticoagulation treatment after discharge and number of VTE events among those patients. Methods: During the period from first of July 2008 till 30 of June 2009, we collected all hospital deaths, all patients with confirmed VTE diagnosis at King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Only patients with confirmed VTE diagnosis were included in the analysis. Results: Five hundred cases with clinical diagnosis of VTE were identified. Out of them 178 were confirmed to be VTE. 36.5% of them received prophylactic antithrombotic therapy. Case fatality rate was 20.8% representing 1.9% of hospital deaths. Case fatality rate was 31% and 3.1% for patients who did not receive thromboprophylaxis and patients who received it, respectively ( P < 0.0001). 66.3% and 33.7% of confirmed VTE cases occurred in surgical and medical patients respectively. Only 44.1% of surgical patients and 21.7% of medical patients received prophylaxis ( P < 0.01). Case fatality rate is 11% for surgical patients and 40% for medical patients (P < 0.001). Of 141 survived cases, 118 (83.7%) were adherent to anticoagulation therapy after discharge. Conclusions: VTE prophylaxis guideline is not properly implemented and extremely underutilized. Mortality from VTE is significantly higher in patients who did not receive VTE prophylaxis. In the absence of regular post-mortem practice VTE related mortality rate would be difficult to estimate and likely will be underestimated. Health authorities should enforce VTE prophylaxis guideline within the healthcare system.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4135    
    Printed178    
    Emailed0    
    PDF Downloaded1535    
    Comments [Add]    
    Cited by others 4    

Recommend this journal